- Jun. 10, 2025
An estimated 7,000 expected to attend Psychedelic Science 2025
An estimated 7,000 expected to attend Psychedelic Science 2025
Renamed center will include clinical care and research
MDMA is one step closer to becoming the first FDA-approved psychedelic drug. In October 2023, the Multidisciplinary Association for Psychedelic Studies (MAPS) announced it completed its phase three clinical trial...